{
  "query": "LLY",
  "resolved": {
    "ticker": "LLY",
    "cik": "0000059478",
    "title": "ELI LILLY & Co"
  },
  "signals": [
    {
      "type": "trial_to_filing",
      "headline": "ELI LILLY & Co (LLY) — PHASE1 protocol updated 5 days ago",
      "entity": "Eli Lilly and Company",
      "ticker": "LLY",
      "cik": "0000059478",
      "tickerConfidence": 0.8166666666666667,
      "upstream": {
        "event": "Clinical trial status (PHASE1)",
        "detail": "A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease",
        "nctId": "NCT06297590",
        "date": "2028-07"
      },
      "observed": {
        "event": "protocol updated 5 days ago",
        "nctId": "NCT06297590"
      },
      "predicted": {
        "event": "SEC 8-K / press release on Phase 2 readout / advance",
        "leadTime": "12-24 mo",
        "baseRate": 0.52,
        "note": "Reg FD requires prompt disclosure of material clinical results."
      },
      "leadTime": "Phase-transition base rate 52% (Wong/Siah/Lo 2019)",
      "confidence": 0.35,
      "links": {
        "trial": "https://clinicaltrials.gov/study/NCT06297590",
        "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000059478&type=8-K"
      }
    },
    {
      "type": "trial_to_filing",
      "headline": "ELI LILLY & Co (LLY) — PHASE3 protocol updated 6 days ago",
      "entity": "Eli Lilly and Company",
      "ticker": "LLY",
      "cik": "0000059478",
      "tickerConfidence": 0.8166666666666667,
      "upstream": {
        "event": "Clinical trial status (PHASE3)",
        "detail": "A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).",
        "nctId": "NCT07602582",
        "date": "2029-09"
      },
      "observed": {
        "event": "protocol updated 6 days ago",
        "nctId": "NCT07602582"
      },
      "predicted": {
        "event": "SEC 8-K / press release on NDA/BLA filing (FDA submission)",
        "leadTime": "12-24 mo",
        "baseRate": 0.58,
        "note": "Reg FD requires prompt disclosure of material clinical results."
      },
      "leadTime": "Phase-transition base rate 57% (Wong/Siah/Lo 2019)",
      "confidence": 0.35,
      "links": {
        "trial": "https://clinicaltrials.gov/study/NCT07602582",
        "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000059478&type=8-K"
      }
    },
    {
      "type": "trial_to_filing",
      "headline": "ELI LILLY & Co (LLY) — PHASE1 protocol updated 12 days ago",
      "entity": "Eli Lilly and Company",
      "ticker": "LLY",
      "cik": "0000059478",
      "tickerConfidence": 0.8166666666666667,
      "upstream": {
        "event": "Clinical trial status (PHASE1)",
        "detail": "A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease",
        "nctId": "NCT07787182",
        "date": "2028-01"
      },
      "observed": {
        "event": "protocol updated 12 days ago",
        "nctId": "NCT07787182"
      },
      "predicted": {
        "event": "SEC 8-K / press release on Phase 2 readout / advance",
        "leadTime": "12-24 mo",
        "baseRate": 0.52,
        "note": "Reg FD requires prompt disclosure of material clinical results."
      },
      "leadTime": "Phase-transition base rate 52% (Wong/Siah/Lo 2019)",
      "confidence": 0.35,
      "links": {
        "trial": "https://clinicaltrials.gov/study/NCT07787182",
        "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000059478&type=8-K"
      }
    }
  ],
  "recentFilings": {
    "name": "ELI LILLY & Co",
    "sicDescription": "Pharmaceutical Preparations",
    "filings": [
      {
        "form": "8-K",
        "date": "2026-10-29",
        "accession": "0000059478-26-000104",
        "items": "2.02,9.01"
      },
      {
        "form": "8-K",
        "date": "2026-08-05",
        "accession": "0000059478-26-000077",
        "items": "2.02,9.01"
      },
      {
        "form": "8-K",
        "date": "2026-05-20",
        "accession": "0001193125-26-232707",
        "items": "8.01,9.01"
      },
      {
        "form": "8-K",
        "date": "2026-05-07",
        "accession": "0000059478-26-000048",
        "items": "5.07"
      },
      {
        "form": "8-K",
        "date": "2026-04-30",
        "accession": "0000059478-26-000043",
        "items": "2.02,9.01"
      }
    ]
  },
  "disclaimer": "Research/informational. NOT investment advice.",
  "generatedAt": "2026-11-03T09:00:20.748Z"
}